Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
33%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_1
3
50%
Ph phase_2
2
33%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
N/A1 (16.7%)

Trials by Status

terminated117%
recruiting117%
withdrawn117%
completed350%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

NCT07058883
completedphase_1

Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects

NCT04920786
withdrawnphase_1

Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)

NCT03769688
completedphase_2

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

NCT02712424
terminatedphase_2

Intranasal Treatment of HIV-associated Neurocognitive Disorders

NCT03277222
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07058883Not Applicable

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

Recruiting
NCT04920786Phase 1

Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects

Completed
NCT03769688Phase 1

Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)

Withdrawn
NCT02712424Phase 2

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

Completed
NCT03277222Phase 2

Intranasal Treatment of HIV-associated Neurocognitive Disorders

Terminated
NCT02476773Phase 1

Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6